Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Lien Ngo"'
Autor:
Lien Ngo, Jaeseong Oh, Anhye Kim, Hyun‐moon Back, Won‐ho Kang, Jung‐woo Chae, Hwi‐yeol Yun, Howard Lee
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 10, Pp 584-595 (2020)
HL2351 (hIL‐1Ra‐hyFc) is a novel recombinant protein formed by the fusion of two human interleukin‐1 receptor antagonist components into one antibody‐derived fragment crystallizable portion. Although HL2351 has a pharmacological mechanism of
Externí odkaz:
https://doaj.org/article/42fafae2b10f4a889c0303af517dd643
Publikováno v:
Optics Communications. 524:128794
Autor:
Steven A. Rosenberg, Zhili Zheng, Yong-Chen Lu, Chuong D. Hoang, Billel Gasmi, Stephanie L. Goff, Paul D. Robbins, Biman C. Paria, Maria R. Parkhurst, Yong Li, Jonathan M. Hernandez, Praveen D. Chatani, Samantha Seitter, Sang-hyun Kim, Drew C. Deniger, Nolan Vale, Maria Florentin, Frank J. Lowery, Sri Krishna, Todd D. Prickett, Sivasish Sindiri, Shoshana Levi, Noam Levin, Victoria Hill, Zhiya Yu, Parisa Malekzadeh, Li Jia, Agnes Y Choi, Elizabeth A. Hedges, Lien Ngo, Jared J. Gartner, Richard M. Sherry, Nikolaos Zacharakis, Satyajit Ray, James Chih-Hsin Yang
Adoptive cell therapy (ACT) targeting neoantigens can achieve durable clinical responses in patients with cancer. Most neoantigens arise from rare mutations, requiring highly individualized treatments. To broaden the applicability of ACT targeting ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba76f22dc2427922bcf92666b5e7cbc
https://doi.org/10.21203/rs.3.rs-916555/v1
https://doi.org/10.21203/rs.3.rs-916555/v1
Autor:
Luong Truong Minh, Lien Ngo Thi
Publikováno v:
Journal of Science Natural Science. 64:89-96
Autor:
Wonku Kang, Keumhan Noh, Thi Lien Ngo, Su-jin Rhee, Jung-woo Chae, Chung-Hee Lee, Hyun-moon Back, Hwi-yeol Yun, Nayoung Han
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 5
International Journal of Molecular Sciences, Vol 21, Iss 5, p 1862 (2020)
Volume 21
Issue 5
International Journal of Molecular Sciences, Vol 21, Iss 5, p 1862 (2020)
Duloxetine (DLX) is a potent drug investigated for the treatment of depression and urinary incontinence. DLX is extensively metabolized in the liver by two P450 isozymes, CYP2D6 and CYP1A2. Propolis (PPL) is one of the popular functional foods known
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 56:292-300
Objective This study was conducted to determine whether a fixed-dose combination (FDC) tablet of repaglinide/metformin (2/500 mg) is equivalent to coadministration of equivalent doses of individual (EDI) tablets of repaglinide (2 mg) and metformin (5
Publikováno v:
European Journal of Pharmaceutical Sciences. 118:154-164
Fixed dose combination (FDC) of valsartan (VAL) and hydrochlorothiazide (HCT) or VAL and amlodipine (AML) has been available in many countries for the treatment of hypertension. Due to drug-drug interaction potentials, in the current study we aimed t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Pharmacokinetics and Pharmacodynamics. 44:291-303
In this study, the population pharmacokinetic (PK) analysis of rebamipide (Reba) in healthy male Korean subjects was analyzed using the nonlinear mixed effects modeling method. The possible effects of physiological covariates and the multidrug resist